Tag: Neuroscience

Mohd Akbar Bhat, Neuroscience, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Mohd Akbar Bhat, Neuroscience, Best Researcher Award

Doctorate Mohd Akbar Bhat: Postdoc Research Fellow at Georgetown University Medical Center, United States

Dr. Mohd Akbar Bhat is an accomplished human geneticist with a profound passion for understanding the genetic causes of complex diseases. With a Ph.D. in Human Genetics from Guru Nanak Dev University, India, Dr. Bhat has spent over a decade researching genetic variations, focusing on retinal degenerative diseases, cardiovascular genetics, and genotoxicity. He has worked in esteemed institutions like Georgetown University and the Dean McGee Eye Institute, where he led research projects exploring molecular and genetic mechanisms behind vision loss, oxidative stress, and cardiovascular pathologies. His multifaceted expertise integrates the application of advanced molecular biology techniques, stem cell biology, and cutting-edge CRISPR technology to unravel the genetic basis of human diseases. Beyond research, Dr. Bhat is dedicated to mentoring the next generation of scientists and collaborating with global experts to foster innovative treatments for genetic disorders.

Online Profiles

Google Scholar Profile

Dr. Bhat is widely recognized for his impactful research contributions, and his professional profiles on platforms like ResearchGate, Google Scholar, and LinkedIn highlight his academic and research accomplishments. These platforms showcase a comprehensive list of his peer-reviewed publications, collaborative research efforts, and ongoing projects in the fields of molecular genetics and ophthalmology. Dr. Bhat’s profiles also facilitate networking with other researchers and experts worldwide, ensuring his work continues to influence the broader scientific community. His active engagement in academic discussions, online seminars, and conferences further enhances his visibility and reputation in the genetics research domain.

Research Metrics

  • Total Citations: 409

  • Citations Since 2020: 357

  • h-index: 11

  • i10-index: 11

Dr. Bhat’s research output has garnered considerable attention, with 409 total citations, and over 350 citations in the last few years alone. His h-index of 11 suggests consistent contributions to the field, while the i10-index of 11 reflects that at least 11 of his publications have been cited 10 or more times, underscoring the impact of his research.

Education

Dr. Bhat’s academic journey began with a deep-rooted interest in human genetics, which led him to pursue a Ph.D. in Human Genetics from Guru Nanak Dev University, Amritsar, India, from 2008 to 2014. During this time, he conducted groundbreaking research on genetic markers associated with human diseases, including age-related macular degeneration and retinitis pigmentosa. His dissertation focused on the molecular genetics of retinal diseases, providing key insights into genetic mutations and their role in visual impairment. Following his doctorate, Dr. Bhat participated in various specialized training programs, strengthening his knowledge of cutting-edge genetic technologies such as next-generation sequencing and CRISPR gene editing, which now underpin much of his current work.

Research Focus

Dr. Bhat’s research spans across various disciplines within molecular genetics, with a primary focus on understanding the genetic and molecular basis of retinal degenerative diseases and cardiovascular genetic disorders. His work involves identifying key genetic mutations and their impact on cellular functions, particularly in retinal neurons and cardiovascular tissues. Additionally, he investigates the role of oxidative stress and genotoxicity in the progression of these diseases. A major area of Dr. Bhat’s research is the development of gene therapies and stem cell-based interventions, including exploring the use of CRISPR technology to correct genetic mutations in retinal cells. By combining his expertise in molecular biology and clinical biochemistry, Dr. Bhat aims to identify new therapeutic targets that could lead to more effective treatments for genetic disorders.

Experience

Dr. Bhat has an extensive research background spanning over a decade, with key roles in both academic and clinical settings. He began his career as a Research Scientist-II at Government Medical College, Amritsar, where he led a variety of genetic studies related to cardiovascular diseases, neurodegenerative diseases, and the identification of genetic biomarkers. Later, Dr. Bhat expanded his expertise during his time at the Dean McGee Eye Institute (2020–2022), where he focused on gene therapy techniques for retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. Most recently, he held a prestigious Postdoctoral Research Fellow position at Georgetown University Medical Center (2022–2024), where his research contributed significantly to the development of new gene-editing approaches to treat genetic mutations in retinal cells. Dr. Bhat’s work is known for its emphasis on translating molecular research into potential clinical applications, bridging the gap between bench science and patient care.

Research Timeline

  • 2008–2014: Dr. Bhat completed his Ph.D. in Human Genetics at Guru Nanak Dev University, India. His research focused on identifying genetic mutations involved in retinal degenerative diseases, providing novel insights into the molecular mechanisms of vision loss.

  • 2014–2015: Dr. Bhat worked as a Researcher in the Department of Human Genetics at Guru Nanak Dev University, contributing to the exploration of genetic polymorphisms in neurodegenerative diseases.

  • 2015–2020: As a Research Scientist-II at the Multidisciplinary Research Unit of Government Medical College, Amritsar, Dr. Bhat led studies on cardiovascular genetics, investigating gene-environment interactions and their impact on disease progression.

  • 2020–2022: Dr. Bhat’s time as a researcher at the Dean McGee Eye Institute focused on genetic therapies for retinal diseases, particularly gene therapies aimed at correcting mutations responsible for vision loss.

  • 2022–2024: During his postdoctoral fellowship at Georgetown University Medical Center, Dr. Bhat conducted cutting-edge research on stem cell-based therapies and CRISPR-mediated gene editing, bringing new hope for patients suffering from inherited retinal diseases.

Awards & Honors

Dr. Bhat has been the recipient of numerous prestigious awards for his research achievements. He was awarded the Best Researcher Award by Guru Nanak Dev University for his contributions to the field of human genetics. Additionally, he received the Young Scientist Award at the International Conference on Molecular Genetics in 2019, recognizing his innovative work in genetic therapies. Dr. Bhat has also been invited to serve as a reviewer for several high-impact journals, further underscoring his influence in the field. His recognition extends beyond academic accolades, with invitations to present his findings at international conferences and symposiums, enhancing the global dialogue on genetic diseases and therapeutic interventions.

Top-Noted Publication

One of Dr. Bhat’s most influential publications is titled “Gene and Stem Cell-Based Therapies for Retinal Degenerative Diseases: Update, Challenges, and Future Directions” published in Stem Cell Reviews and Reports (2025). This paper offers a comprehensive review of the latest advancements in gene therapy and stem cell-based interventions for retinal degenerative diseases, highlighting emerging therapeutic strategies and their clinical implications. His research has also been featured in journals such as Human Genetics and Molecular Vision, where he discusses the genetic pathways involved in retinal disorders and the potential for personalized treatments. These contributions have made Dr. Bhat a leading figure in ophthalmic genetics, influencing both clinical practices and research in the field.

  • A Case-Control Association Study of APOE Promoter Region Variants with Glaucoma in the North Indian Population
    S. Passan, S. Goyal, M.A. Bhat, R. Singh, M. Kaur, V. Vanita
    Human Immunology, 86(3), 111299
    2025
    This study explores the genetic association between variants in the APOE promoter region and the risk of developing glaucoma in a North Indian cohort. The findings have implications for early genetic screening and potential therapeutic interventions for glaucoma in this population.

  • Age-Related Retinal Degeneration Resulting from the Deletion of Shp2 Tyrosine Phosphatase in Photoreceptor Neurons
    A. Rajala, R. Rajala, M.A. Bhat, M. Eminhizer, J. Hao, J. Du, R.V.S. Rajala
    Cell Death & Disease, 15(8), 577
    2024
    This paper presents groundbreaking research on the role of Shp2 tyrosine phosphatase in the regulation of retinal degeneration. The deletion of Shp2 in photoreceptor neurons resulted in accelerated retinal degeneration, offering a potential new pathway for therapeutic strategies in age-related retinal diseases.

  • Sex-Dependent Regulation of RPE and Retinal Function by Pgc-1α During Aging in Mice
    K. Taskintuna, M.A. Bhat, T. Shaikh, J.R. Hum, N. Golestaneh
    Investigative Ophthalmology & Visual Science, 65(7), 4988-4988
    2024
    This study investigates the differential effects of Pgc-1α, a key regulator of mitochondrial biogenesis, on retinal pigment epithelium (RPE) and overall retinal function across sexes in aging mice. The findings reveal important insights into sex-specific vulnerabilities to age-related retinal diseases.

  • Phosphatidylinositol 5-Kinase (PIKfyve) Negatively Regulates Photoreceptor Neuroprotection
    R.V.S. Rajala, M.A. Bhat, K. Teel, A. Rajala
    Investigative Ophthalmology & Visual Science, 63(7), 3820-3820
    2022
    In this article, the authors demonstrate that PIKfyve, an enzyme involved in lipid signaling, negatively regulates photoreceptor survival under stress conditions. The study provides potential new targets for therapies aimed at protecting retinal cells from degenerative diseases.

  • Genetic Damage Biomarkers in Buccal Epithelial Cells of Healthy Individuals Staying Near Three Mobile Phone Base Stations
    G.G. Naresh Mahajan, Akbar Bhat
    International Conference on Human Genetics and 39th Annual Meeting of the…
    2014
    This study investigates genetic damage in healthy individuals living near mobile phone base stations, highlighting the impact of electromagnetic radiation on human health, with a focus on genetic biomarkers of oxidative stress and cellular damage.

  • A Prospective, Randomized, Open Label Study to Assess the Role of Vitamin C as an Adjuvant to Paroxetine in Pharmacotherapy of Major Depressive Disorder
    K. Aggarwal, N.R. Singh, N. Bala, M.A. Bhat, S.K. Jain, S. Thakur, R. Sood
    This clinical trial aimed to evaluate the effectiveness of vitamin C as an adjunct therapy to paroxetine in treating major depressive disorder. The study found potential benefits in combining nutritional supplements with pharmacotherapy to enhance clinical outcomes in depression management.

ISABEL Martinez-Pena y Valenzuela, Neuroscience, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on ISABEL Martinez-Pena y Valenzuela, Neuroscience, Best Researcher Award

Dr. Isabel Martinez-Peña y Valenzuela: Assistant Professor at Midwestern University, United States

Dr. Isabel Martinez-Peña y Valenzuela is an accomplished neuroscientist with extensive expertise in the molecular and cellular biology of synapses, particularly at the neuromuscular junction (NMJ). She is currently an Assistant Professor in the Physiology Department at Midwestern University’s College of Graduate Studies and College of Dental Medicine. Her career spans over two decades, including significant contributions at institutions such as the University of Michigan and University of La Laguna, Spain. She is widely recognized for her mentorship of students, impactful research on synaptic pathology in metabolic and neurodegenerative diseases, and dedication to both teaching and academic service.

Online Profiles

Google Scholar Profile

As of July 2025, Dr. Martinez-Peña y Valenzuela has accumulated 673 citations overall, with 285 citations since 2020. Her h-index is 16 (10 since 2020), and her i10-index is 19 (11 since 2020), reflecting both the quality and continued relevance of her contributions to the field of neuroscience and neuromuscular biology.

Dr. Martinez-Peña maintains active academic profiles showcasing her publications and collaborations. Her Google Scholar profile reflects a robust citation record in synaptic biology and neuroscience, while her NCBI MyBibliography includes a comprehensive list of peer-reviewed journal articles, conference proceedings, and reviews. These profiles highlight her long-standing research productivity and the translational impact of her studies in neuromuscular function and dysfunction.

Education

She earned her Ph.D. in Neuroscience from the University of La Laguna (ULL), Spain, with a thesis titled “Alterations of the cerebrospinal fluid proteins and subcommissural organ secretion in arterial hypertension and ventricular dilatation: A study in SHR rats.” Her doctoral research laid the foundation for her lifelong interest in cerebrospinal physiology and brain-body communication. Dr. Martinez-Peña also holds a Bachelor of Science in Molecular and Cellular Biology from ULL’s Faculty of Biology, equipping her with interdisciplinary training in physiology, pathology, and molecular medicine.

Research Focus

Her research program explores the structure and function of the neuromuscular synapse under both physiological and pathological conditions. Using transgenic mouse models and in vivo imaging, her lab investigates how obesity, Parkinson’s disease, cancer-induced cachexia, and sleep apnea contribute to synaptic disassembly, impaired neurotransmission, and muscle dysfunction. Dr. Martinez-Peña also studies the role of specific proteins such as acetylcholinesterase, α-dystrobrevin, and α-syntrophin in maintaining synaptic integrity, with the ultimate goal of identifying therapeutic targets for neuromuscular disorders.

Experience

Dr. Martinez-Peña has held a range of academic and research positions in Spain and the United States. She began as an Anatomy Instructor at ULL (1998–2002), followed by postdoctoral training in gastrointestinal and developmental neuroscience at the University of Michigan (2003–2008). From 2009 to 2020, she was a Research Investigator at Michigan’s Department of Molecular, Cellular, and Developmental Biology, where she led independent and collaborative studies on synaptic biology. She later served as a Visiting Assistant Professor at Kalamazoo College (2020–2022), where she taught physiology and mentored undergraduate research. Since 2022, she has been a full-time faculty member at Midwestern University.

Research Timeline

Dr. Martinez-Peña’s research journey began in Spain with studies on the cerebrospinal system and neuroendocrine regulation. In the early 2000s, she transitioned to the University of Michigan, conducting postdoctoral work on neuromuscular physiology. By 2009, she had established herself as an independent investigator, contributing extensively to the fields of synaptic maintenance and neurodegeneration.

Awards & Honors

She has received multiple recognitions for her academic excellence and research mentorship, including the Doctorate Summa Cum Laude from the University of La Laguna and the Cajal Club Fellowship in Madrid (2001). She was honored with the Most Valuable Professor award by Kalamazoo College’s intercollegiate athletics program in 2022 and was selected as a finalist in the 2024 American Medical Association Research Challenge. Additionally, her students have won regional research presentation awards, highlighting her impact as both a scientist and mentor.

Top-Noted Publication

One of Dr. Martinez-Peña’s most influential publications is her 2022 study in Human Molecular Genetics, titled “Distinct roles of the dystrophin-glycoprotein complex: α-dystrobrevin and α-syntrophin in the maintenance of the postsynaptic apparatus of the neuromuscular synapse.” This paper elucidates the molecular mechanisms regulating NMJ stability and offers insights into therapeutic strategies for neuromuscular disorders. It has been widely cited and reflects her leading role in bridging basic and translational neuroscience.
DOI: 10.1093/HMG/ddac041

Dr. Martinez-Peña y Valenzuela’s most impactful research has significantly advanced understanding of the neuromuscular junction, with several landmark studies cited widely in the field of neuroscience and molecular biology:

  1. Schmidt N, Akaaboune M, Gajendran N, Martinez-Pena y Valenzuela I, et al. (2011).
    “Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin.”
    Journal of Cell Biology, 195(7):1171–1184.
    This foundational paper, cited 122 times, describes the molecular signaling mechanisms involving Neuregulin/ErbB and α-dystrobrevin in NMJ development.
    Link

  2. Herranz-Martin S, Chandran J, Lewis K, Martinez-Pena y Valenzuela I, et al. (2017).
    “Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits.”
    Disease Models & Mechanisms, 10(7):859–868.
    Cited 59 times, this study provides insights into C9orf72-mediated ALS and FTD pathology using a mouse model.
    Link

  3. Krejci E, Martinez-Pena y Valenzuela I, Ameziane R, Akaaboune M. (2006).
    “Acetylcholinesterase dynamics at the neuromuscular junction of live animals.”
    Journal of Biological Chemistry, 281(15):10347–10354.
    This work, cited 46 times, explores real-time regulation of AChE at the NMJ, contributing to understanding of synaptic maintenance.
    Link

  4. Martinez-Pena y Valenzuela I, Pires-Oliveira M, Akaaboune M. (2013).
    “PKC and PKA regulate AChR dynamics at the neuromuscular junction of living mice.”
    PLoS ONE, 8(11):e81311.
    Cited 44 times, this study reveals how key kinases modulate receptor turnover and synaptic plasticity in vivo.
    Link

  5. Martinez-Pena y Valenzuela I, Mouslim C, Akaaboune M. (2010).
    “Calcium/calmodulin kinase II-dependent acetylcholine receptor cycling at the mammalian neuromuscular junction in vivo.”
    Journal of Neuroscience, 30(37):12455–12465.
    Also cited 44 times, this article details the role of CaMKII in receptor recycling, providing mechanistic insights into NMJ regulation.
    Link

Mini Dahiya, Neuroscience, Young Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Mini Dahiya, Neuroscience, Young Researcher Award

Asst. Prof. Mini Dahiya: Assistant Professor (Guest Faculty) at Panjab University, India

Dr. Mini Dahiya is a passionate academic and neuropharmacology researcher with over six years of experience in pharmaceutical sciences. Currently serving as an Assistant Professor (Guest Faculty) at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, she is also a Ph.D. scholar under the guidance of Prof. Anil Kumar. Her work integrates molecular neuroscience, pharmacology, and disease modeling to explore novel therapeutic strategies for Alzheimer’s disease. Recognized for her academic excellence, Dr. Dahiya is a gold medalist in M.Pharmacy and has presented her research at prestigious platforms including the Alzheimer’s Association International Conference (AAIC). Her work is grounded in both basic science and translational goals, contributing meaningfully to the neurodegenerative disease research landscape in India and globally.

Online Profiles

Scopus Profile

Dr. Mini Dahiya actively maintains a professional digital footprint to share her research and academic work. Her Google Drive portfolio provides open access to select publications, conference materials, and project updates (view here). She is also a registered pharmacist with the Haryana State Pharmacy Council (Reg. No. 26370), and a member of ISTAART, the Alzheimer’s Association’s International Society to Advance Alzheimer’s Research and Treatment (ID: 200067175673).

University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India. Her Scopus record includes 15 published documents, which have collectively received 17 citations, reflecting the growing recognition of her contributions to neuropharmacology and pharmaceutical sciences. She holds an h-index of 3, indicating a consistent citation impact across multiple works.

Education

Dr. Dahiya’s academic journey began with a Bachelor’s degree in Pharmacy from G.V.M. College of Pharmacy, Sonipat, affiliated with UHS Rohtak, where she achieved a solid academic standing. She then pursued her M.Pharmacy in Pharmacology at Chaudhary Bansi Lal University, Bhiwani, graduating with distinction as a Gold Medalist in 2019. Her doctoral research, currently underway at Panjab University, focuses on targeting insulin signaling in Alzheimer’s-type dementia, blending behavioral neuroscience, pharmacological intervention, and biochemical assay techniques. Throughout her studies, she has demonstrated consistent academic performance, intellectual curiosity, and a growing research impact in neuropharmacology.

Research Focus

Her primary research revolves around the insulin signaling mechanism in the pathophysiology of Alzheimer’s disease, especially in the context of sporadic dementia. Using ICV-STZ-induced models, she investigates how brain insulin resistance contributes to memory loss, oxidative stress, mitochondrial dysfunction, and neuroinflammation. She is exploring phytochemical-based therapeutic interventions such as β-pinene and fenchone, aiming to reverse or mitigate neurodegenerative changes through multi-targeted strategies. In addition, her research portfolio includes drug repurposing, nanomedicine formulation, and mitochondrial biology, with a translational focus on developing novel treatment approaches for age-related cognitive disorders.

Experience

Dr. Dahiya brings a strong blend of academic, research, and pharmaceutical experience. Since July 2020, she has served as Assistant Professor (Guest Faculty) at Panjab University, contributing to undergraduate and postgraduate pharmacology education while actively conducting research in the Pharmacology Lab. From 2019 to 2020, she worked as an Assistant Professor at Shri Gopichand College of Pharmacy, Baghpat, where she delivered lectures and mentored students in pharmaceutical sciences. Earlier, from 2014 to 2017, she gained industry exposure as a pharmacist at Sunor Medi International, Sonipat. This combination of teaching, laboratory, and clinical experience shapes her as a well-rounded pharmaceutical professional.

Research Timeline

Dr. Mini Dahiya began her formal research journey during her M.Pharmacy (2017–2019) with a dissertation on herbal nanoformulations for prostate cancer therapy. In 2020, she enrolled as a Ph.D. scholar at Panjab University, focusing on experimental models of Alzheimer’s disease. Over the years, she has contributed to several collaborative research projects involving natural products, drug repurposing, and mechanistic studies related to memory impairment, mitochondrial dysfunction, and oxidative damage. Her growing publication record, conference presentations, and textbook authorship demonstrate a continuous and evolving engagement in pharmaceutical research from bench to bedside.

Awards & Honors

Dr. Dahiya’s academic and research excellence has been recognized through multiple prestigious awards and fellowships. She was honored with a Gold Medal during her M.Pharm degree and secured First Rank in the Panjab University Ph.D. entrance exam. She has been a PU Ph.D. Fellow (2020–2023) and received international travel grants from the Alzheimer’s Association to attend AAIC conferences in Amsterdam (2023) and Philadelphia (2024). Notably, she served as an abstract review committee member at AAIC 2024—an exceptional recognition for an early-career researcher. Her participation in SERB-DST ‘Karyashala’ workshops and national-level conferences further underlines her commitment to academic excellence.

Top-Noted Publication

Among her numerous peer-reviewed publications, the most cited and influential work is the study titled “β-pinene ameliorates ICV-STZ induced Alzheimer’s pathology via antioxidant, anticholinesterase, and mitochondrial protective effects”, accepted in the European Journal of Pharmacology. This comprehensive research combines in-silico docking studies, behavioral assessments, and biochemical evaluations to validate the neuroprotective potential of β-pinene in Alzheimer’s disease models. The paper highlights the multi-target pharmacological approach and strengthens the relevance of phytochemicals in neurodegenerative disease therapy, positioning it as a cornerstone of her current research impact.

Peer-Reviewed Journal Articles

  1. Dahiya, M., Kumar, A., Yadav, M., Chauhan, S. (2025). β-pinene ameliorates ICV-STZ induced Alzheimer’s pathology via antioxidant, anticholinesterase, and mitochondrial protective effects: In-silico and in-vivo studies. European Journal of Pharmacology. (Accepted)

  2. Dahiya, M., Goyal, C., Kumar, A. (2025). Insulin Resistance and Alzheimer’s Disease: Unraveling the Link Between Metabolism and Memory. Journal of Pharmacology & Clinical Research, 10(5), 555800. (Accepted)

  3. Mini, M. (2024). Exploring the neuroprotective effects of fenchone against ICV-STZ-induced sporadic Alzheimer’s disease in rats. Alzheimer’s & Dementia, 20, e091350.

  4. Dahiya, M., Yadav, M., Kumar, S., Chauhan, S., Lamba, D. (2024). GC–MS Analysis and Fabrication of Nanoparticles of Buchanania lanzan Oil for the Anticancer Activity. Research Journal of Pharmacy and Technology, 17(10), 4699–4706. [DOI: 10.52711/0974-360X.2024.00724]

  5. Yadav, M., Parle, M., Lamba, D., Kumar, S., Dahiya, M., Joshi, K. (2024). Neuroprotective effect of dark chocolate on ketamine-induced psychosis. Journal of Advanced Zoology, 45(2).

  6. Yadav, M., Dahiya, M., Dagar, J., Singh, N., Sharma, N., Rawat, N., Dhakla, P., Minocha, N., Kumar, A. (2022). Role of mitochondria in brain functions and related disorders. Exploration of Medicine. [DOI: 10.37349/emed.2022.00110]

  7. Kaushik, J., Yadav, M., Sharma, N., Jindal, D.K., Joshi, K., Dahiya, M., Deep, A. (2022). Phytochemical analysis and biological activities of Emblica officinalis. Anti-Infective Agents, 20(4). [DOI: 10.2174/2211352520666220318091023]

  8. Yadav, M., Kumar, A., Kumar, N., Jindal, D.K., Dahiya, M. (2021). Possible biomarkers and contributing factors of psychosis: A review. Current Pharmacology Reports, 1–12.

  9. Dahiya, M., Kumar, A., Yadav, M. (2020). Role of insulin signaling in Alzheimer’s disease. International Journal of Psychology and Behavioral Science, 16(1), 555926.

  10. Yadav, M., Dahiya, M., Rawat, N., Kumar, A. (2020). Mammalian Target of Rapamycin (mTOR): An Emerging Drug Target for Neurological Disorders. SunText Review Neuroscience Psychology, 1(3), 120.

  11. Dhull, S., Ishu, Dahiya, M., Kadian, M., Yadav, M. (2019). Authentication of edible oils using analytical techniques. Clinical Journal of Pharmacology and Pharmacotherapeutics, 1, 035–040.

Marwa Soliman, Neuroscience, Best Researcher Award

Posted on by scizentoxLeave a Comment on Marwa Soliman, Neuroscience, Best Researcher Award

Dr. Marwa Soliman: Senior Research Assistant at Burke Neurological Institute, United States

Marwa Soliman is a graduate student pursuing a Master of Computer Science with a focus on Big Data Systems at Arizona State University. With a background in both Computer Science and Biology, she is passionate about applying computational techniques to biological research, particularly in the field of neuroscience. Currently a Senior Research Assistant at the Burke Neurological Institute, she combines her expertise in data analysis, image processing, and deep learning to support cutting-edge research on spinal cord injury and circuit repair.

Online Profiles

Research Metrics
  • Total Citations: 17
  • Citations Since 2020: 17
  • h-index: 1
  • i10-index: 1

These metrics reflect a growing body of research with impactful contributions in the fields of neuroscience and motor learning, highlighting the relevance and influence of your work in advancing scientific understanding.

Education

Marwa is currently pursuing her Master of Computer Science in Big Data Systems at Arizona State University, expected to graduate in June 2025. She holds a B.A. in Computer Science and a B.A. in Biology, both earned summa cum laude from Manhattanville University, where she achieved a GPA of 3.91/4.00. Her academic journey has equipped her with a strong foundation in data science, machine learning, and computational biology.

Research Focus

Her primary research interests revolve around utilizing big data systems, machine learning, and image analysis to better understand neurological conditions, particularly spinal cord injury and neuroregeneration. Marwa is actively working on automating high-dimensional biological data analysis, integrating behavioral and neural activity data, and exploring gene networks related to axonal regeneration.

Experience

As a Senior Research Assistant at the Burke Neurological Institute, Marwa specializes in image and data analysis, with a focus on automating complex biological datasets, such as RNA sequencing and KDI analysis. She is proficient in using tools like DeepLabCut, OpenCV, and Python to analyze behavioral videos, and she leads efforts in 3D printing and laser cutting within the lab. Additionally, she has contributed to the development of synchronized systems that link motor behavior to neural recordings, advancing research on neurodegenerative diseases.

Research Timeline

Marwa’s research timeline spans from her undergraduate years, where she developed deep-learning algorithms for early skin cancer detection, to her current work in spinal cord injury research. At Manhattanville University, she worked on skin cancer detection algorithms during the summer of 2019. From 2020 onwards, she has been involved in more advanced projects at the Burke Neurological Institute, focusing on motion function assessment and neuroregeneration through data-driven tools and techniques.

Awards & Honors

Marwa has received multiple honors, including the Computer Science Department Honors Award, Biology Department Honors Award, and the prestigious Daughters for Life Scholarship in 2016. She was also a finalist at the Intel ISEF in 2014 and has been recognized for leadership and outstanding service, notably receiving the Leadership and Outstanding Service Award from the Mary T. Clark Center for Religion and Social Justice in 2019.

Top-Noted Publication

  • Task-specific modulation of corticospinal neuron activity during motor learning in mice
    N Serradj, F Marino, Y Moreno-López, A Bernstein, S Agger, M Soliman, …
    Nature Communications, 14(1), 2708, 2023
    This study explored how task-specific activities modulate corticospinal neuron function during motor learning, shedding light on how skilled motor behavior impacts the neural circuits responsible for voluntary movement.

  • A Kinematic Deviation Index (KDI) for Evaluation of Forelimb Function in Rodents
    A Torres-Espin, A Bernstein, M Soliman, JS Jara, Y Moreno-López, …
    bioRxiv, 1, 2024
    This paper introduced the Kinematic Deviation Index (KDI), a novel metric for assessing forelimb function in rodents, providing a more precise tool for evaluating motor deficits and recovery in animal models of neurological disorders.

  • Acute Extrinsic Activation of the RANKL Pathway Decreases Wound Healing and Functional Recovery After Spinal Cord Injury in Mice
    AL Vivinetto, A Bernstein, M Soliman, JW Cave, E Hollis
    Glia, 2025
    This publication explored how acute activation of the RANKL pathway impairs both wound healing and functional recovery following spinal cord injury, highlighting a potential target for therapeutic intervention.

  • Conditioning electrical stimulation enhances functional rewiring in a mouse model of nerve transfer to treat chronic spinal cord injury
    JS Jara, M Soliman, A Bernstein, P di Grazia, AR Ferguson, JM Brown, …
    bioRxiv, 2025.01.17.633666
    This study demonstrated that conditioning electrical stimulation enhances functional rewiring in a mouse model of nerve transfer for treating chronic spinal cord injury, providing promising insights into improving recovery outcomes.

  • Task-specific modulation of corticospinal neuron activity during skilled motor learning
    N Serradj, F Marino, Y Moreno-López, A Bernstein, S Agger, M Soliman, …
    bioRxiv, 2021.03.22.436415
    In this earlier work, the team investigated how skilled motor learning drives changes in corticospinal neuron activity, contributing to our understanding of the neural mechanisms underlying motor skill acquisition.

Yilong Wang, Neuroscience, Best Researcher Award

Posted on by scizentoxLeave a Comment on Yilong Wang, Neuroscience, Best Researcher Award

Dr. Yilong Wang: Executive Vice President, Professor of Neuroscience, Chief Physician at Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Dr. Yilong Wang, a distinguished neurologist and academic leader, serves as the Executive Vice President and Chief Physician at Beijing Tiantan Hospital, Capital Medical University. His expertise lies in cerebrovascular diseases and rare neurological disorders, with a particular focus on precision treatment strategies and innovative drug delivery systems. With extensive academic experience, including a postdoctoral fellowship at the University of California, he has made substantial contributions to stroke and small vessel disease research.

Online Profiles

ORCID Profile

Dr. Wang’s online presence is marked by his significant contributions to neuroscience and stroke research. He holds leadership roles in several academic societies, including the Chinese Stroke Association and the Chinese Medical Association. His research, particularly in stroke prevention and treatment, has gained international attention, with multiple publications in top-tier journals like NEJM and JAMA. He also serves as an editorial board member for Stroke & Vascular Neurology and the Chinese Stroke Journal.

Education

Dr. Wang’s academic foundation includes a Ph.D. in Neurology from Capital Medical University, complemented by a Master’s in Epidemiology and Health Statistics from North China Coal Medical College. He further honed his expertise through a postdoctoral fellowship in Neurology at the University of California, San Francisco, School of Medicine, from 2007 to 2009, where he expanded his research into cerebrovascular and neurological diseases.

Research Focus

Dr. Wang’s research focuses on cerebrovascular diseases, particularly ischemic stroke, and rare neurological disorders. His work explores precision diagnostic technologies, stroke prevention, and novel drug delivery methods that bypass the blood-brain barrier. His interdisciplinary research also involves medical-engineering crossover innovations, including intelligent medical devices and brain-computer interfaces, to improve neurological disease management and outcomes.

Experience

Dr. Wang’s professional trajectory spans various leadership positions at Beijing Tiantan Hospital, including Executive Vice President, Vice President, and Deputy Director of the Neurology Center. He has also held significant roles in the hospital’s scientific and technological departments, contributing to advancements in medical research, clinical practices, and technology integration for cerebrovascular diseases.

Research Timeline

Dr. Wang’s research has been supported by numerous national and international grants. His key projects include studies on precision treatment strategies for acute ischemic stroke and cerebral small vessel diseases. From 2019 to 2023, he led the National Natural Science Foundation of China’s Outstanding Youth Science Fund project, contributing to groundbreaking work on ischemic stroke therapies and intervention techniques. His ongoing research addresses innovative drug delivery systems and vascular disease treatment strategies.

Awards & Honors

Dr. Wang has earned numerous prestigious awards, including the National “Ten Thousand Talents Plan” Leading Talent in Science and Technology Innovation and the Young Scholar award from the Chang Jiang Scholars Program. He has also been recognized with various science and technology progress awards, both nationally and internationally, for his contributions to cerebrovascular disease research and innovations in medical technology.

Top-Noted Publication

Dr. Wang’s landmark publications include his recent work in NEJM (2023), where he introduced a dual-target intensive antiplatelet therapy for mild strokes, significantly impacting clinical treatment approaches. Another key publication in JAMA Neurology (2024) explored the role of statin therapy in neuroprotection during acute ischemic stroke, establishing him as a leader in stroke research. His work continues to shape medical guidelines for stroke prevention and treatment worldwide.

  • Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack
    Published in JAMA on July 5, 2016. This study explored the influence of CYP2C19 loss-of-function allele status on the effectiveness of clopidogrel, providing insights into personalized stroke prevention strategies.
    DOI: 10.1001/jama.2016.8662
  • Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial
    Published in Circulation on July 7, 2015. This article discussed the results of the CHANCE trial, examining the combination of clopidogrel and aspirin in reducing the risk of stroke recurrence in patients with minor strokes or transient ischemic attacks.
    DOI: 10.1161/circulationaha.114.014791
  • Prevalence, Knowledge, and Treatment of Transient Ischemic Attacks in China
    Published in Neurology on June 9, 2015. This study highlighted the prevalence and public awareness of transient ischemic attacks in China, along with the treatment approaches, contributing valuable data to the global understanding of stroke management in the region.
    DOI: 10.1212/wnl.0000000000001665